Matthew Hamilton Rosenberg’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.5K | Hold |
60
| – | – | 0.01% | 503 |
|
|
2025
Q1 | $38.1K | Hold |
60
| – | – | 0.01% | 465 |
|
|
2024
Q4 | $42.7K | Sell |
60
-6
| -9% | -$4.27K | 0.01% | 442 |
|
|
2024
Q3 | $69.4K | Hold |
66
| – | – | 0.02% | 377 |
|
|
2024
Q2 | $69.8K | Hold |
66
| – | – | 0.02% | 366 |
|
|
2024
Q1 | $64K | Hold |
66
| – | – | 0.02% | 388 |
|
|
2023
Q4 | $58K | Buy |
66
+6
| +10% | +$5.27K | 0.02% | 405 |
|
|
2023
Q3 | $49.4K | Hold |
60
| – | – | 0.02% | 423 |
|
|
2023
Q2 | $43.1K | Hold |
60
| – | – | 0.01% | 456 |
|
|
2023
Q1 | $49.3K | Hold |
60
| – | – | 0.02% | 467 |
|
|
2022
Q4 | $43.3K | Hold |
60
| – | – | 0.01% | 495 |
|
|
2022
Q3 | $41K | Hold |
60
| – | – | 0.02% | 487 |
|
|
2022
Q2 | $36K | Hold |
60
| – | – | 0.01% | 521 |
|
|
2022
Q1 | $42K | Hold |
60
| – | – | 0.01% | 481 |
|
|
2021
Q4 | $38K | Buy |
+60
| New | +$38K | 0.01% | 457 |
|